EMD Millipore Introduces New CEO & President
EMD Millipore recently announced the appointment of Udit Batra, PhD, as its incoming President and CEO, responsible for the organization’s strategic direction to drive growth and product innovation as well as oversight of the worldwide operations. Dr. Batra will assume leadership effective May 15, 2014, and be based at the company’s US headquarters in Massachusetts.
“As a global leader in the Life Sciences industry, I am very humbled and excited to be a part of EMD Millipore team and look forward to serving our customers globally,” said Dr. Batra. “As a former researcher who personally utilized the strong differentiated products that EMD Millipore offers, I have watched this organization develop over the past several years, and look forward to further building upon that success to bring continued value to our customers and other stakeholders.”
Dr. Batra comes to EMD Millipore from the Consumer Health division of Merck KGaA, where he successfully grew the business in established and emerging markets. He previously worked at Novartis Vaccines & Diagnostics, where he was Head of Global Public Health and Market Access. Prior to that, he served in a range of executive management positions at Novartis, including global Head of Corporate Strategy and Country President for the Pharma Business in Australia.
Dr. Batra started his career as a Research Engineer at Merck & Co. In 2001, he joined McKinsey where he worked across the healthcare, consumer, and nonprofit sectors as a Senior Engagement Manager. In 2004, he was appointed global Brand Director for the Wound Care Franchise at Johnson & Johnson, before joining Novartis in 2006.
Dr. Batra is a member of the WSMI (World Self Medication Industry) and the Chair of the Food Supplements Committee of the AESGP (Association of the European Self-Medication Industry). He holds a PhD in Chemical Engineering from Princeton University and a BS in Chemical Engineering from the University of Delaware.
EMD Millipore is the Life Science division of Merck KGaA of Germany and offers a broad range of innovative, performance products, services, and business relationships that enable customers’ success in research, development, and production of biotech and pharmaceutical drug therapies. For more information, visit www.emdmillipore.com.
Total Page Views: 1538
